Vir Biotechnology Inc. (VIR)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

2,248,249 $14,568,654 -31% 0.35%
2. 1,617,228 $10,479,638 +497% 0%
3. 1,120,400 $7,260,192 -10% 0.01%
4.
Ikarian Capital

Neil Shahrestani

1,068,062 $6,921,041 +19% 0.85%
5.
Catalio Capital Management

George Petrocheilos And R. Jacob Vogelstein

611,608 $3,963,220 0.96%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$22.73 2,500 Director 10,000 2023-03-01 Filing
$24.96 2,500 Director 7,500 2023-01-05 Filing
$25.25 2,500 Director 5,000 2023-01-04 Filing
$25.60 2,500 Director 2,500 2023-01-03 Filing
$43.39 12 Officer 12 2021-11-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.95 79,712 Officer, Director 769,505 2025-04-03 Filing
$9.14 7,373 Officer 79,460 2025-02-26 Filing
$9.45 10,056 Director 698,239 2025-02-24 Filing
$9.45 14,168 Officer 117,901 2025-02-24 Filing
$9.45 1,562 Officer 46,627 2025-02-24 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 16,684,041 $108,112,586 0.99%
2. 16,541,330 $107,187,817 0%
3. 12,807,508 $82,992,651 0%
4. 5,727,163 $37,112,016 0%
5. 2,684,415 $17,396,913 0%
News See All